×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
山东大学 [17]
内容类型
期刊论文 [12]
会议论文 [5]
发表日期
2019 [17]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共17条,第1-10条
帮助
限定条件
发表日期:2019
专题:山东大学
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
The impact of epidermal growth factor receptor mutations on the efficacy of definitive chemoradiotherapy in patients with locally advanced unresectable stage III non-small cell lung cancer: a systematic review and meta-analysis
期刊论文
Expert review of anticancer therapy, 2019, 卷号: 19, 期号: 6, 页码: 533-539
作者:
Qin Q.
;
Peng B.
;
Li B.
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2019/12/11
chemoradiotherapy
epidermal growth factor receptor
Non-small cell lung cancer
Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer
期刊论文
EUROPEAN RADIOLOGY, 2019, 卷号: 29, 期号: 6, 页码: 2958-2967
作者:
Wang, Linlin
;
Dong, Taotao
;
Xin, Bowen
;
Xu, Chongrui
;
Guo, Meiying
收藏
  |  
浏览/下载:50/0
  |  
提交时间:2019/12/11
Non-small cell lung cancer
Radiomics
Nomogram
Prognosis
Delineating the pattern of treatment for elderly locally advanced NSCLC and predicting outcomes by a validated model: A SEER based analysis
期刊论文
CANCER MEDICINE, 2019, 卷号: 8, 期号: 5, 页码: 2587-2598
作者:
Guo, Meiying
;
Li, Butuo
;
Yu, Yishan
;
Wang, Shijiang
;
Xu, Yiyue
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/12/11
CSS
Geriatric
Locally advanced nonsmall-cell lung cancer
nomogram
OS
SEER
Programmed death-ligand 1 expression and CD8+tumor-infiltrating lymphocytes in advanced non-small cell lung cancer treated with microwave ablation and chemotherapy
期刊论文
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2019, 卷号: 35, 期号: 1, 页码: 591-598
作者:
Wei, Zhigang
;
Zhan, Xuemei
;
Fan, Linlin
;
Ye, Xin
;
Yang, Xia
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/11
PD-L1
CD8+TIL
microwave ablation
chemotherapy
progression-free
survival
overall survival
The impact of previous therapy strategy on the efficiency of anlotinib hydrochloride as a third-line treatment on patients with advanced non-small cell lung cancer (NSCLC): a subgroup analysis of ALTER0303 trial
期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 卷号: 8, 期号: 5, 页码: 575-+
作者:
Wang, Lili
;
He, Zhen
;
Yang, Sen
;
Tang, Hong
;
Wu, Yufeng
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/11
Non-small cell lung cancer (NSCLC)
anlotinib
antiangiogenic therapy
The Kinetic Changes of Systemic Inflammatory Factors during Bevacizumab Treatment and Its Prognostic Role in Advanced Non-small Cell Lung Cancer Patients
期刊论文
JOURNAL OF CANCER, 2019, 卷号: 10, 期号: 21, 页码: 5082-5089
作者:
Li, Butuo
;
Wang, Shijiang
;
Li, Cheng
;
Guo, Meiying
;
Xu, Yiyue
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/12/11
systemic immune status
mixed effect model
longitudinal changes
prognostic factors
survival analysis
A Randomized Phase III Study of Cisplatin-Polymeric Micelle Paclitaxel vs Cisplatin-Solvent-Based Paclitaxel in 1st Line Advanced NSCLC
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 10, 页码: S304-S304
作者:
Wu, Y.
;
Han, B.
;
Shi, M.
;
Tu, H.
;
Gu, A.
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/11
advanced non-small cell lung cancer
Polymeric micelle paclitaxel
(pm-Pac) /cisplatin
randomized phase III clinical trial
Microwave ablation or plus monochemotherapy in elderly advanced non-small-cell lung cancer patients
期刊论文
Minimally Invasive Therapy and Allied Technologies, 2019
作者:
Wei Z.
;
Li Q.
;
Ye X.
;
Yang X.
;
Huang G.
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/11
microwave ablation
Non-small-cell lung cancer
overall survival
progression-free survival
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303
期刊论文
THORACIC CANCER, 2019, 卷号: 10, 期号: 3, 页码: 551-556
作者:
Si, Xiaoyan
;
Zhang, Li
;
Wang, Hanping
;
Zhang, Xiaotong
;
Wang, Mengzhao
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2019/12/11
Adverse event
anlotinib
multi-target tyrosine kinase inhibitor
non-small cell lung cancer
Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy
期刊论文
FUTURE ONCOLOGY, 2019, 卷号: 15, 期号: 6, 页码: 625-635
作者:
Guo, Dong
;
Li, Minghuan
;
Chen, Dawei
;
Jing, Wang
;
Zhu, Hui
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/11
advanced
chemotherapy
first-line
neutrophil-to-lymphocyte ratio
non-small-cell lung cancer
platelet-to-lymphocyte ratio
platinum
predictor
prognostic
superior
©版权所有 ©2017 CSpace - Powered by
CSpace